Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

DW-MRI and DCE-MRI are of complementary value in predicting pathologic response to neoadjuvant chemoradiotherapy for esophageal cancer.

Heethuis SE, Goense L, van Rossum PSN, Borggreve AS, Mook S, Voncken FEM, Bartels-Rutten A, Aleman BMP, van Hillegersberg R, Ruurda JP, Meijer GJ, Lagendijk JJW, van Lier ALHMW.

Acta Oncol. 2018 May 21:1-8. doi: 10.1080/0284186X.2018.1473637. [Epub ahead of print]

PMID:
29781342
2.

Limited additional value of cervical ultrasonography over a negative 18F-FDG PET/CT for diagnosing cervical lymph node metastases in patients with esophageal cancer: a systematic review and meta-analysis.

Goense L, Meziani J, van Rossum PSN, Wessels FJ, Meijer GJ, Lam MGEH, van Hillegersberg R, Ruurda JP.

Nucl Med Commun. 2018 Apr 18. doi: 10.1097/MNM.0000000000000847. [Epub ahead of print]

PMID:
29672463
3.

Postoperative pain management after esophagectomy: a systematic review and meta-analysis.

Visser E, Marsman M, van Rossum PSN, Cheong E, Al-Naimi K, van Klei WA, Ruurda JP, van Hillegersberg R.

Dis Esophagus. 2018 Apr 13. doi: 10.1093/dote/doy033. [Epub ahead of print] No abstract available.

PMID:
29668925
4.

Defining pneumonia after esophagectomy for cancer: validation of the Uniform Pneumonia Score in a high volume center in North America.

Seesing MFJ, Wirsching A, van Rossum PSN, Weijs TJ, Ruurda JP, van Hillegersberg R, Low DE.

Dis Esophagus. 2018 Apr 14. doi: 10.1093/dote/doy002. [Epub ahead of print]

PMID:
29668913
5.

Role of adjuvant chemoradiotherapy after endoscopic treatment of early-stage esophageal cancer: a systematic review.

Goense L, Meziani J, Borggreve AS, van Rossum PS, Meijer GJ, Ruurda JP, van Hillegersberg R, Weusten BL.

Minerva Chir. 2018 Apr 13. doi: 10.23736/S0026-4733.18.07763-5. [Epub ahead of print]

PMID:
29658684
6.

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma.

Goense L, van Rossum PSN, Xi M, Maru DM, Carter BW, Meijer GJ, Ho L, van Hillegersberg R, Hofstetter WL, Lin SH.

Ann Surg Oncol. 2018 Jun;25(6):1598-1607. doi: 10.1245/s10434-018-6435-4. Epub 2018 Mar 22.

7.

Patient perspectives on repeated MRI and PET/CT examinations during neoadjuvant treatment of esophageal cancer.

Goense L, Borggreve AS, Heethuis SE, van Lier AL, van Hillegersberg R, Mook S, Meijer GJ, van Rossum PS, Ruurda JP.

Br J Radiol. 2018 Mar 14:20170710. doi: 10.1259/bjr.20170710. [Epub ahead of print]

PMID:
29498535
8.

Role of neoadjuvant chemoradiotherapy in clinical T2N0M0 esophageal cancer: A population-based cohort study.

Goense L, Visser E, Haj Mohammad N, Mook S, Verhoeven RHA, Meijer GJ, van Rossum PSN, Ruurda JP, van Hillegersberg R.

Eur J Surg Oncol. 2018 May;44(5):620-625. doi: 10.1016/j.ejso.2018.02.005. Epub 2018 Feb 13.

PMID:
29478739
9.

Generalized cardiovascular disease on a preoperative CT scan is predictive for anastomotic leakage after esophagectomy.

Borggreve AS, Goense L, van Rossum PSN, van Hillegersberg R, de Jong PA, Ruurda JP.

Eur J Surg Oncol. 2018 May;44(5):587-593. doi: 10.1016/j.ejso.2018.01.225. Epub 2018 Feb 2.

PMID:
29452856
10.

Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends.

van Rossum PSN, Mohammad NH, Vleggaar FP, van Hillegersberg R.

Nat Rev Gastroenterol Hepatol. 2018 Apr;15(4):235-249. doi: 10.1038/nrgastro.2017.162. Epub 2017 Dec 13. Review.

PMID:
29235549
11.

Cervical ultrasonography has no additional value over negative 18F-FDG PET/CT scans for diagnosing cervical lymph node metastases in patients with oesophageal cancer.

Goense L, Meziani J, van Rossum PSN, Wessels FJ, Lam MGEH, van Hillegersberg R, Ruurda JP.

Eur Radiol. 2018 May;28(5):2031-2037. doi: 10.1007/s00330-017-5136-x. Epub 2017 Dec 7.

12.

A structured training program for minimally invasive esophagectomy for esophageal cancer- a Delphi consensus study in Europe.

Visser E, van Rossum PSN, van Veer H, Al-Naimi K, Chaudry MA, Cuesta MA, Gisbertz SS, Gutschow CA, Hölscher AH, Luyer MDP, Mariette C, Moorthy K, Nieuwenhuijzen GAP, Nilsson M, Räsänen JV, Schneider PM, Schröder W, Cheong E, van Hillegersberg R.

Dis Esophagus. 2018 Mar 1;31(3). doi: 10.1093/dote/dox124.

PMID:
29121243
13.

Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer.

Goense L, Heethuis SE, van Rossum PSN, Voncken FEM, Lagendijk JJW, Lam MGEH, Terhaard CH, van Hillegersberg R, Ruurda JP, Mook S, van Lier ALHMW, Lin SH, Meijer GJ.

Nucl Med Commun. 2018 Jan;39(1):60-67. doi: 10.1097/MNM.0000000000000771.

PMID:
29023336
14.

Postoperative pain management after esophagectomy: a systematic review and meta-analysis.

Visser E, Marsman M, van Rossum PSN, Cheong E, Al-Naimi K, van Klei WA, Ruurda JP, van Hillegersberg R.

Dis Esophagus. 2017 Oct 1;30(10):1-11. doi: 10.1093/dote/dox052.

PMID:
28859388
15.

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S; COMPASS Investigators.

N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27.

16.

Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the Netherlands.

Visser E, van Rossum PSN, Ruurda JP, van Hillegersberg R.

Ann Surg. 2017 Nov;266(5):863-869. doi: 10.1097/SLA.0000000000002389.

PMID:
28742691
17.

Community-Based Lifestyle Intervention in Patients With Coronary Artery Disease: The RESPONSE-2 Trial.

Minneboo M, Lachman S, Snaterse M, Jørstad HT, Ter Riet G, Boekholdt SM, Scholte Op Reimer WJM, Peters RJG; RESPONSE-2 Study Group.

J Am Coll Cardiol. 2017 Jul 18;70(3):318-327. doi: 10.1016/j.jacc.2017.05.041.

PMID:
28705312
18.

Diagnostic performance of a CT-based scoring system for diagnosis of anastomotic leakage after esophagectomy: comparison with subjective CT assessment.

Goense L, Stassen PMC, Wessels FJ, van Rossum PSN, Ruurda JP, van Leeuwen MS, van Hillegersberg R.

Eur Radiol. 2017 Oct;27(10):4426-4434. doi: 10.1007/s00330-017-4802-3. Epub 2017 Mar 29.

19.

Association Between Waiting Time from Diagnosis to Treatment and Survival in Patients with Curable Gastric Cancer: A Population-Based Study in the Netherlands.

Brenkman HJF, Visser E, van Rossum PSN, Siesling S, van Hillegersberg R, Ruurda JP.

Ann Surg Oncol. 2017 Jul;24(7):1761-1769. doi: 10.1245/s10434-017-5820-8. Epub 2017 Mar 28.

20.

The diagnostic performance of 18F-FDG PET/CT, CT and MRI in the treatment evaluation of ablation therapy for colorectal liver metastases: A systematic review and meta-analysis.

Samim M, Molenaar IQ, Seesing MF, van Rossum PS, van den Bosch MA, Ruers TJ, Borel Rinkes IH, van Hillegersberg R, Lam MG, Verkooijen HM.

Surg Oncol. 2017 Mar;26(1):37-45. doi: 10.1016/j.suronc.2016.12.006. Epub 2016 Dec 29. Review.

PMID:
28317583

Supplemental Content

Loading ...
Support Center